Device Trial Radar · NCT03173664
Post-Approval Study With the KAMRA Inlay
Last checked: Nov 19, 2026Latest source record: May 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
529
Planned (sponsor's estimate)
Start
Jul 31, 2018
Primary completion
Jan 2026
Study completion Jan 2026
Sponsor
- Lead sponsor
- AcuFocus, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 2, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
KAMRA inlay, to be unilaterally implanted into the cornea of a subject's non-dominant eye. The inlay is to be inserted into a stromal pocket created with a surgical femtosecond laser.
Conditions
- Presbyopia
Interventions
KAMRA InlayDevice
Unilateral implantation of the KAMRA inlay in the corneal stroma.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Monocular Near Visual AcuityTime frame: Five years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.